Home » High-Quality Health Information » Health Topics » Adrenocortical Carcinoma » Study: NCT00831844

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Status:	Recruiting participants
Conditions:	Adrenocortical Carcinoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
Interventions:	Biological: cixutumumab; Other: laboratory biomarker analysis
Institutions:	Dana-Farber Cancer Institute
Health Topics:	Adrenocortical Carcinoma, Ewing's Sarcoma, Kidney Cancer, Liver Cancer, Neuroblastoma, Retinopathy
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012